Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices 80573 

representatives of WTC responders as 

well as representatives of certifiedeligible WTC survivors. 

DATES: Nominations for membership on 

the STAC must be received no later than 

November 11, 2024. Packages received 

after this time will not be considered for 

the current membership cycle. 

ADDRESSES: All nominations should be 

mailed to NIOSH Docket 229–L, c/o Mia 

Wallace, Committee Management 

Specialist, National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, 1600 Clifton Road NE, 

Mailstop V24–4, Atlanta, Georgia 

30329–4027, or emailed to 

nioshdocket@cdc.gov. 

FOR FURTHER INFORMATION CONTACT: 

Tania Carreo ́n-Valencia, Ph.D., M.S., 

Designated Federal Officer, World Trade 

Center Health Program Scientific/ 

Technical Advisory Committee, Centers 

for Disease Control and Prevention, 

1600 Clifton Road NE, Mailstop R–12, 

Atlanta, Georgia 30329–4027. 

Telephone: (513) 841–4515 (this is not 

a toll-free number); Email: 

TCarreonValencia@cdc.gov. 

SUPPLEMENTARY INFORMATION: The World 

Trade Center (WTC) Health Program 

Scientific/Technical Advisory 

Committee (STAC) reviews scientific 

and medical evidence and makes 

recommendations to the Administrator 

of the WTC Health Program on 

additional Program eligibility criteria 

and, upon request, additional WTCrelated health conditions, reviews and 

evaluates policies and procedures used 

to determine whether sufficient 

evidence exists to support adding a 

health condition to the List of WTCRelated Health Conditions (List), makes 

recommendations regarding individuals 

to conduct independent peer reviews of 

the scientific and technical evidence 

underlying a final rule adding a 

condition to the List, and provides 

consultation on research regarding 

certain health conditions related to the 

September 11, 2001, terrorist attacks. 

Nominations are sought for 

individuals with the expertise and 

qualifications necessary to accomplish 

the Committee’s objectives. The 

Administrator of the WTC Health 

Program is seeking nominations for 

members fulfilling the following 

categories: 

• Two occupational physicians, one 

of whom should have experience 

treating WTC rescue and recovery 

workers; 

• Environmental medicine/ 

environmental health professional; 

• Toxicologist; 

• Epidemiologist; 

• Representative of WTC responders; 

and 

• Representative of certified-eligible 

WTC survivors. 

Members may be invited to serve for 

four-year terms. Selection of members is 

based on candidates’ qualifications to 

contribute to accomplishing STAC 

objectives. More information on the 

Committee is available at https://

www.cdc.gov/wtc/stac.html. 

Department of Health and Human 

Services (HHS) policy stipulates that 

committee membership be balanced in 

terms of points of view represented and 

the committee’s function. Appointments 

shall be made without discrimination 

on the basis of age, race, ethnicity, 

gender, sexual orientation, gender 

identity, HIV status, disability, and 

cultural, religious, or socioeconomic 

status. Nominees must be U.S. citizens. 

Current participation on Federal 

workgroups or prior experience serving 

on a Federal advisory committee does 

not disqualify a candidate; however, 

HHS policy is to avoid excessive 

individual service on advisory 

committees and multiple committee 

memberships. Committee members are 

Special Government Employees, 

requiring the filing of financial 

disclosure reports at the beginning of 

and annually during their terms. NIOSH 

identifies potential candidates and 

provides a slate of nominees for 

consideration to the Director of the 

Centers for Disease Control and 

Prevention (CDC) for STAC membership 

each year; CDC reviews the proposed 

slate of candidates and provides a slate 

of nominees for consideration to the 

Secretary of HHS for final selection. 

HHS notifies selected candidates of 

their appointment near the start of the 

term in October, or as soon as the HHS 

selection process is completed. Note 

that the need for different expertise 

varies from year to year and a candidate 

who is not selected in one year may be 

reconsidered in a subsequent year. 

Candidates should submit the 

following items: 

• Current curriculum vitae, including 

complete contact information 

(telephone numbers, mailing address, 

email address); 

• The category of membership 

(environmental medicine or 

environmental health specialist, 

occupational physician, pulmonary 

physician, representative of WTC 

responders, certified-eligible WTC 

survivor representative, industrial 

hygienist, toxicologist, epidemiologist, 

or mental health professional) that the 

candidate is qualified to represent; 

• A summary of the background, 

experience, and qualifications that 

demonstrates the candidate’s suitability 

for the nominated membership category 

along with an indication of whether the 

candidate is currently enrolled in the 

WTC Health Program; and 

• At least one letter of 

recommendation from person(s) not 

employed by HHS. Candidates may 

submit letter(s) from current HHS 

employees if they wish, but at least one 

letter must be submitted by a person not 

employed by an HHS agency (e.g., CDC, 

National Institutes of Health, Food and 

Drug Administration). 

Nominations may be submitted by the 

candidate or by the person/organization 

recommending the candidate. 

The Director, Office of Strategic 

Business Initiatives, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Office of Strategic Business 

Initiatives, Office of the Chief Operating 

Officer, Centers for Disease Control and 

Prevention. 

[FR Doc. 2024–22866 Filed 10–2–24; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Health Resources and Services 

Administration 

Meeting of the Advisory Committee on 

Heritable Disorders in Newborns and 

Children 

AGENCY: Health Resources and Services 

Administration (HRSA), Department of 

Health and Human Services. 

ACTION: Notice. 

SUMMARY: In accordance with the 

Federal Advisory Committee Act, this 

notice announces that the Advisory 

Committee on Heritable Disorders in 

Newborns and Children (ACHDNC or 

Committee) has scheduled a public 

meeting. Information about ACHDNC 

and the agenda for this meeting can be 

found on the ACHDNC website at 

https://www.hrsa.gov/advisorycommittees/heritable-disorders/ 

index.html. 

DATES: Thursday, November 14, 2024, 

from 10 a.m. to 4 p.m. eastern time (ET). 

ADDRESSES: This meeting will be held 

via webinar. While this meeting is open 

to the public, advance registration is 


ddrumheller on DSK120RN23PROD with NOTICES1
80574 Federal Register / Vol. 89, No. 192 / Thursday, October 3, 2024 / Notices 

required. Please visit the ACHDNC 

website for information on registration: 

https://www.hrsa.gov/advisorycommittees/heritable-disorders/ 

index.html. Register no later than 12:00 

p.m. ET on November 13, 2024. 

Instructions on how to access the 

meeting via webcast will be provided 

upon registration. 

FOR FURTHER INFORMATION CONTACT: 

Leticia Manning, Maternal and Child 

Health Bureau, HRSA, 5600 Fishers 

Lane, Room, Rockville, Maryland 20857; 

301–443–8335; or ACHDNC@hrsa.gov. 

SUPPLEMENTARY INFORMATION: ACHDNC 

provides advice and recommendations 

to the Secretary of Health and Human 

Services (Secretary) on the development 

of newborn screening activities, 

technologies, policies, guidelines, and 

programs for effectively reducing 

morbidity and mortality in newborns 

and children having, or at risk for, 

heritable disorders. ACHDNC reviews 

and reports regularly on newborn and 

childhood screening practices, 

recommends improvements in the 

national newborn and childhood 

screening programs, and fulfills 

requirements stated in the authorizing 

legislation. In addition, ACHDNC’s 

recommendations regarding inclusion of 

additional conditions for screening on 

the Recommended Uniform Screening 

Panel, following adoption by the 

Secretary, are evidence-informed 

preventive health services provided for 

in the comprehensive guidelines 

supported by HRSA pursuant to section 

2713 of the Public Health Service Act 

(42 U.S.C. 300gg–13). Under this 

provision, non-grandfathered group 

health plans and health insurance 

issuers offering non-grandfathered 

group or individual health insurance are 

required to provide insurance coverage 

without cost-sharing (a co-payment, coinsurance, or deductible) for preventive 

services for plan years (i.e., policy years) 

beginning on or after the date that is 1 

year from the Secretary’s adoption of the 

condition for screening. 

During the November 14, 2024, 

meeting, ACHDNC will hear from 

experts in the fields of public health, 

medicine, heritable disorders, rare 

disorders, and newborn screening. 

Possible agenda items may include the 

following topics: 

(1) An update on the development of 

a newborn screening family outcomes 

tool, 

(2) A panel presentation on funding 

opportunities for research that includes 

the lived experience, 

(3) A presentation on the Newborn 

Screening Information Center, and 

(4) An update on Recommended 

Uniform Screening Panel condition 

nomination submissions. 

Agenda items are subject to change as 

priorities dictate. Information about 

ACHDNC, including a roster of members 

and past meeting summaries, is 

available on the ACHDNC website listed 

above. 

Members of the public will have the 

opportunity to provide comments on 

any of the above agenda items. Public 

participants may request to provide 

general oral comments and may submit 

written statements in advance of the 

scheduled meeting. Oral comments will 

be honored in the order they are 

requested and may be limited as time 

allows. Requests to provide a written 

statement or make oral comments to 

ACHDNC must be submitted via the 

registration website by 12:00 p.m. ET on 

Thursday, October 31, 2024. Written 

comments will be shared with the 

Committee prior to the meeting so they 

have an opportunity to consider them in 

advance of the meeting. 

Individuals who need special 

assistance or another reasonable 

accommodation should notify Leticia 

Manning at the address and phone 

number listed above at least 10 business 

days prior to the meeting. 

Maria G. Button, 

Director, Executive Secretariat. 

[FR Doc. 2024–22733 Filed 10–2–24; 8:45 am] 

BILLING CODE 4165–15–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Charter Renewal of the Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria 

AGENCY: Office of the Assistant 

Secretary for Health, Office of the 

Secretary, Department of Health and 

Human Services. 

ACTION: Notice. 

SUMMARY: As stipulated by the Federal 

Advisory Committee Act, the 

Department of Health and Human 

Services (HHS) is hereby giving notice 

that the charter for the Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria 

(PACCARB) has been renewed. 

FOR FURTHER INFORMATION CONTACT: 

Jomana Musmar, M.S., Ph.D., 

Designated Federal Officer, Presidential 

Advisory Council on Combating 

Antibiotic-Resistant Bacteria, Office of 

the Assistant Secretary for Health, U.S. 

Department of Health and Human 

Services, 1101 Wootton Parkway, 

Rockville, MD 20852. Phone: 202–746– 

1512; Email: CARB@hhs.gov. 

SUPPLEMENTARY INFORMATION: The 

Presidential Advisory Council on 

Combating Antibiotic-Resistant Bacteria 

(PACCARB), established by Executive 

Order 13676, is continued by section 

505 of Public Law 116–22, the 

Pandemic and All-Hazards 

Preparedness and Advancing Innovation 

Act of 2019 (PAHPAIA). Activities and 

duties of the PACCARB are governed by 

the provisions of the Federal Advisory 

Committee Act (FACA), Public Law 92– 

463, as amended (5 U.S.C. app.), which 

sets forth standards for the formation 

and use of Federal advisory committees. 

FACA stipulates that the charter for a 

Federal advisory committee must be 

renewed every two years. 

The PACCARB shall advise and 

provide information and 

recommendations to the Secretary of 

Health and Human Services (Secretary) 

regarding programs and policies 

intended to reduce or combat antibioticresistant bacteria that may present a 

public health threat and improve 

capabilities to prevent, diagnose, 

mitigate, or treat such resistance. The 

PACCARB shall function solely for 

advisory purposes. 

Such advice, information, and 

recommendations may be related to 

improving: the effectiveness of 

antibiotics; research and advanced 

research on, and the development of, 

improved and innovative methods for 

combating or reducing antibiotic 

resistance, including new treatments, 

rapid point-of-care diagnostics, 

alternatives to antibiotics, including 

alternatives to animal antibiotics, and 

antimicrobial stewardship activities; 

surveillance of antibiotic-resistant 

bacterial infections, including publicly 

available and up-to-date information on 

resistance to antibiotics; education for 

health care providers and the public 

with respect to up-to-date information 

on antibiotic resistance and ways to 

reduce or combat such resistance to 

antibiotics related to humans and 

animals; methods to prevent or reduce 

the transmission of antibiotic-resistant 

bacterial infections; including 

stewardship programs; and coordination 

with respect to international efforts in 

order to inform and advance the United 

States capabilities to combat antibiotic 

resistance. 

On August 29, 2024, the Secretary of 

Health and Human Services approved 

the renewal of the PACCARB’s charter. 

The new charter was executed and filed 

with the appropriate Congressional 

committees and the Library of Congress 

on August 29, 2024. The renewal of the 


ddrumheller on DSK120RN23PROD with NOTICES1